Literature DB >> 28286455

Clinical Applications of Esophageal Multichannel Intraluminal Impedance Testing.

Radu Tutuian1, Donald O Castell1.   

Abstract

Multichannel intraluminal impedance is a relatively new technology that allows detection of bolus movement in the gastrointestinal tract without the use of radiation. In clinical applications it is combined with manometry, allowing a better evaluation of the functional characteristics (ie, bolus transit) of esophageal motility abnormalities. When combined with pH monitoring, it provides more comprehensive data on both acid and nonacid gastroesophageal reflux.

Entities:  

Keywords:  Multichannel intraluminal impedance (MII); combined multichannel intraluminal impedance–manometry testing; combined multichannel intraluminal impedance–pH monitoring

Year:  2006        PMID: 28286455      PMCID: PMC5335680     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  25 in total

1.  Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole.

Authors:  M F Vela; L Camacho-Lobato; R Srinivasan; R Tutuian; P O Katz; D O Castell
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

2.  Prolonged pH recording in the study of gastro-oesophageal reflux.

Authors:  J Spencer
Journal:  Br J Surg       Date:  1969-12       Impact factor: 6.939

3.  Effect of esophageal emptying and saliva on clearance of acid from the esophagus.

Authors:  J F Helm; W J Dodds; L R Pelc; D W Palmer; W J Hogan; B C Teeter
Journal:  N Engl J Med       Date:  1984-02-02       Impact factor: 91.245

4.  The burden of selected digestive diseases in the United States.

Authors:  Robert S Sandler; James E Everhart; Mark Donowitz; Elizabeth Adams; Kelly Cronin; Clifford Goodman; Eric Gemmen; Shefali Shah; Aida Avdic; Robert Rubin
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

5.  Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.

Authors:  Donald O Castell; Peter J Kahrilas; Joel E Richter; Nimish B Vakil; David A Johnson; Seth Zuckerman; Wendy Skammer; Jeffrey G Levine
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

6.  Multichannel intraluminal impedance accurately detects fasting, recumbent reflux events and their clearing.

Authors:  Steven S Shay; Steven Bomeli; Joel Richter
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-08       Impact factor: 4.052

7.  Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring.

Authors:  D Sifrim; L Dupont; K Blondeau; X Zhang; J Tack; J Janssens
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

8.  Symptom and function heterogenicity among patients with distal esophageal spasm: studies using combined impedance-manometry.

Authors:  Radu Tutuian; Inder Mainie; Amit Agrawal; R Matthew Gideon; Philip O Katz; Donald O Castell
Journal:  Am J Gastroenterol       Date:  2006-03       Impact factor: 10.864

9.  Esophageal function testing with combined multichannel intraluminal impedance and manometry: multicenter study in healthy volunteers.

Authors:  Radu Tutuian; Marcelo F Vela; Nagammapudur S Balaji; James L Wise; Joseph A Murray; Jeffrey H Peters; Steven S Shay; Donald O Castell
Journal:  Clin Gastroenterol Hepatol       Date:  2003-05       Impact factor: 11.382

10.  Clarification of the esophageal function defect in patients with manometric ineffective esophageal motility: studies using combined impedance-manometry.

Authors:  Radu Tutuian; Donald O Castell
Journal:  Clin Gastroenterol Hepatol       Date:  2004-03       Impact factor: 11.382

View more
  1 in total

1.  Improving High-resolution Impedance Manometry Using Novel Viscous and Super-viscous Substrates in the Supine and Upright Positions: A Pilot Study.

Authors:  Uni Wong; Erik B Person; Donald O Castell; Erik von Rosenvinge; Jean-Pierre Raufman; Guofeng Xie
Journal:  J Neurogastroenterol Motil       Date:  2018-10-01       Impact factor: 4.924

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.